bioMérieux has introduced the BIOFIRE ® SPOTFIRE ® system for rapid mycoplasma testing in pharmaceutical manufacturing. The instrument provides automated sample processing and delivers molecular ...

BEVERLY, Mass., Jan. 18, 2023 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), an innovative, molecular ...

SAFENSURE ™ Mycoplasma Rapid Detection Kit (qPCR) is a validated NAT-based mycoplasma rapid detection kit designed to accelerate in-process and lot-release testing. Broad coverage - The kit ...

MARCY-L'ÉTOILE, France, April 9, 2026 /PRNewswire/ -- bioMérieux, a world leader in the field of in vitro diagnostics, announces the launch of BIOFIRE® SPOTFIRE® for pharmaceutical industries, where ...

Mycoplasma contamination is a persistent issue in cell culture and biopharmaceutical manufacturing. Mycoplasmas are widespread in the environment and are commonly found on human mucosal surfaces.

The rapid growth of the biologics safety testing market has led to the need for more testing capabilities in manufacturing and clinical research. Industry guidelines require biopharmaceutical and ...

In the face of a bacterium that easily resists common antibiotics, members of UAB established testing to identify it in human disease. Mycoplasma, that is. Mycoplasmas are the smallest free-living ...

Advanced Therapy Medicinal Products are revolutionizing treatment for severe diseases, but ensuring their safety before administration remains complex. Traditional Mycoplasma testing methods can delay ...

Cell culture is a deliciously inviting hub for bacteria, fungi, and mycoplasmas. However, as our own 'cell-culture sleuth' points out, failing to detect and eliminate contamination can alter all ...

The US Food and Drug Administration (FDA) issued a proposed rule on Monday to remove the required testing method to detect the presence of Mycoplasma because FDA said the regulation is restrictive in ...